Director
Moderna Therapeutics
Jason DelCarpini has been working the field of regulated bioanalysis for over 20 years. Over that time, he has acquired extensive experience developing and validating PK, PD, and immunogenicity assays for various modalities including protein therapeutics, gene & cell therapy, and mRNA therapeutics. He is currently an Associate Director of Bioanalytical and Molecular Assays at Moderna where he leads the LBA team for in-house PK, PD and Immunogenicity analysis.